Published Medical IKK-Alpha Cancer Treatment Scientists at Strathclyde have developed the first reported potent and selective IKK alpha inhibitors, and our lead compound has been shown to achieve 60% tumour growth inhibition By University of Strathclyde
Published Medical Mammalian Extracellular Matrix Preserves native ECM proteins for optimal cell growth that mimics the complex tissue environment to produce more clinically relevant data for improved translational outcome. By Washington State University
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
